Europe Androgenetic Alopecia Market Size, Share & Trends Analysis Report By Treatment (Pharmaceuticals, and Devices), By Gender (Male, and Female), By Sales Channel, By Country and Growth Forecast, 2023

List of Tables

The Europe Androgenetic Alopecia Market would witness market growth of 7.9% CAGR during the forecast period (2023-2030).

The Germany market dominated the Europe Androgenetic Alopecia Market, By Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $288.9 Million by 2030. The UK market is registering a CAGR of 6.9% during (2023 - 2030). Additionally, The France market would showcase a CAGR of 8.7% during (2023 - 2030).

Many individuals adopt cosmetic solutions to conceal hair loss temporarily. Wigs, hairpieces, and fibers offer immediate aesthetic improvement without medical or surgical interventions. Robotic systems are being increasingly utilized in hair transplant procedures. These systems enhance the precision of follicle extraction and transplantation, leading to more natural-looking results and reduced recovery times. AI plays a significant role in the diagnosis and treatment planning for androgenetic alopecia. Algorithms analyze patient data, including genetic information, to provide personalized recommendations. This data-driven approach enhances the accuracy of diagnoses and improves treatment outcomes.

There is a growing recognition of the psychosocial impact of androgenetic alopecia. The market is witnessing a trend towards interventions that not only address the physical aspects of hair loss but also consider the emotional well-being of individuals. This holistic approach aligns with broader trends in healthcare that prioritize mental health. Janus kinase (JAK) inhibitors, traditionally used in treating autoimmune conditions, are being explored for their potential in treating androgenetic alopecia. Topical formulations of JAK inhibitors are undergoing clinical trials, representing a novel approach to stimulate hair growth.

As the aging population in Europe grows, there is a natural increase in the number of people experiencing hair loss, creating a larger pool of potential consumers for androgenetic alopecia treatments. As the aging population becomes more health-conscious and informed, there is an increased awareness of available treatments for androgenetic alopecia in Europe. The aging population in Europe may contribute to the growth of medical tourism for hair restoration procedures. Thus, all these factors will uplift the regional market's expansion in the coming years.

Based on Treatment, the market is segmented into Pharmaceuticals, and Devices. Based on Gender, the market is segmented into Male, and Female. Based on Sales Channel, the market is segmented into Prescriptions, and OTC. Based on End-use, the market is segmented into Dermatology Clinics, and Homecare Settings. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

Cipla Limited
Merck & Co., Inc.
GlaxoSmithKline PLC (GSK)
Sun Pharmaceuticals Industries Ltd.
Dr. Reddy's Laboratories Ltd.
Aurobindo Pharma Limited
Pfizer, Inc.
Lutronic Co., Ltd.
Viatris Inc.
Eli Lilly and Company

Europe Androgenetic Alopecia Market Report Segmentation

By Treatment

Pharmaceuticals
Devices

By Gender

Male
Female

By Sales Channel

Prescriptions
OTC

By End-use

Dermatology Clinics
Homecare Settings

By Country

Germany
UK
France
Russia
Spain
Italy
Rest of Europe

Chapter 1.Market Scope & Methodology

1.1Market Definition
1.2Objectives
1.3Market Scope
1.4Segmentation
- 1.4.1Europe Androgenetic Alopecia Market, by Treatment
- 1.4.2Europe Androgenetic Alopecia Market, by Gender
- 1.4.3Europe Androgenetic Alopecia Market, by Sales Channel
- 1.4.4Europe Androgenetic Alopecia Market, by End-use
- 1.4.5Europe Androgenetic Alopecia Market, by Country
1.5Methodology for the research

Chapter 2.Market at a Glance

2.1Key Highlights

Chapter 3.Market Overview

3.1Introduction
- 3.1.1Overview
  - 3.1.1.1Market Composition and Scenario
3.2Key Factors Impacting the Market
- 3.2.1Market Drivers
- 3.2.2Market Restraints
- 3.2.3Market Opportunities
- 3.2.4Market Challenges
3.3Porter Five Forces Analysis

Chapter 4.Europe Androgenetic Alopecia Market, By Treatment

4.1Europe Pharmaceuticals Market, By Country
4.2Europe Devices Market, By Country

Chapter 5.Europe Androgenetic Alopecia Market, By Gender

5.1Europe Male Market, By Country
5.2Europe Female Market, By Country

Chapter 6.Europe Androgenetic Alopecia Market, By Sales Channel

6.1Europe Prescriptions Market, By Country
6.2Europe OTC Market, By Country

Chapter 7.Europe Androgenetic Alopecia Market, By End-use

7.1Europe Dermatology Clinics Market, By Country
7.2Europe Homecare Settings Market, By Country

Chapter 8.Europe Androgenetic Alopecia Market, By Country

8.1Germany Androgenetic Alopecia Market
- 8.1.1Germany Androgenetic Alopecia Market, By Treatment
- 8.1.2Germany Androgenetic Alopecia Market, By Gender
- 8.1.3Germany Androgenetic Alopecia Market, By Sales Channel
- 8.1.4Germany Androgenetic Alopecia Market, By End-use
8.2UK Androgenetic Alopecia Market
- 8.2.1UK Androgenetic Alopecia Market, By Treatment
- 8.2.2UK Androgenetic Alopecia Market, By Gender
- 8.2.3UK Androgenetic Alopecia Market, By Sales Channel
- 8.2.4UK Androgenetic Alopecia Market, By End-use
8.3France Androgenetic Alopecia Market
- 8.3.1France Androgenetic Alopecia Market, By Treatment
- 8.3.2France Androgenetic Alopecia Market, By Gender
- 8.3.3France Androgenetic Alopecia Market, By Sales Channel
- 8.3.4France Androgenetic Alopecia Market, By End-use
8.4Russia Androgenetic Alopecia Market
- 8.4.1Russia Androgenetic Alopecia Market, By Treatment
- 8.4.2Russia Androgenetic Alopecia Market, By Gender
- 8.4.3Russia Androgenetic Alopecia Market, By Sales Channel
- 8.4.4Russia Androgenetic Alopecia Market, By End-use
8.5Spain Androgenetic Alopecia Market
- 8.5.1Spain Androgenetic Alopecia Market, By Treatment
- 8.5.2Spain Androgenetic Alopecia Market, By Gender
- 8.5.3Spain Androgenetic Alopecia Market, By Sales Channel
- 8.5.4Spain Androgenetic Alopecia Market, By End-use
8.6Italy Androgenetic Alopecia Market
- 8.6.1Italy Androgenetic Alopecia Market, By Treatment
- 8.6.2Italy Androgenetic Alopecia Market, By Gender
- 8.6.3Italy Androgenetic Alopecia Market, By Sales Channel
- 8.6.4Italy Androgenetic Alopecia Market, By End-use
8.7Rest of Europe Androgenetic Alopecia Market
- 8.7.1Rest of Europe Androgenetic Alopecia Market, By Treatment
- 8.7.2Rest of Europe Androgenetic Alopecia Market, By Gender
- 8.7.3Rest of Europe Androgenetic Alopecia Market, By Sales Channel
- 8.7.4Rest of Europe Androgenetic Alopecia Market, By End-use

Chapter 9.Company Profiles

9.1Cipla Limited
- 9.1.1Company Overview
- 9.1.2Financial Analysis
- 9.1.3Segmental and Regional Analysis
- 9.1.4Research & Development Expense
- 9.1.5SWOT Analysis
9.2Merck & Co., Inc.
- 9.2.1Company Overview
- 9.2.2Financial Analysis
- 9.2.3Segmental and Regional Analysis
- 9.2.4Research & Development Expenses
- 9.2.5SWOT Analysis
9.3GlaxoSmithKline PLC (GSK)
- 9.3.1Company Overview
- 9.3.2Financial Analysis
- 9.3.3Regional Analysis
- 9.3.4Research & Development Expense
- 9.3.5SWOT Analysis
9.4Sun Pharmaceuticals Industries Ltd.
- 9.4.1Company Overview
- 9.4.2Financial Analysis
- 9.4.3Regional Analysis
- 9.4.4Research & Development Expenses
- 9.4.5SWOT Analysis
9.5Dr. Reddy's Laboratories Ltd.
- 9.5.1Company Overview
- 9.5.2Financial Analysis
- 9.5.3Segmental and Regional Analysis
- 9.5.4Research & Development Expense
- 9.5.5Recent strategies and developments:
  - 9.5.5.1Product Launches and Product Expansions:
- 9.5.6SWOT Analysis
9.6Aurobindo Pharma Limited
- 9.6.1Company Overview
- 9.6.2Financial Analysis
- 9.6.3Regional Analysis
- 9.6.4Research & Development Expense
- 9.6.5SWOT Analysis
9.7Pfizer, Inc.
- 9.7.1Company Overview
- 9.7.2Financial Analysis
- 9.7.3Regional & Segmental Analysis
- 9.7.4Research & Development Expense
- 9.7.5Recent strategies and developments:
  - 9.7.5.1Trails and Approvals:
- 9.7.6SWOT Analysis
9.8Lutronic Co., Ltd.
- 9.8.1Company Overview
- 9.8.2Financial Analysis
- 9.8.3Regional Analysis
- 9.8.4Research & Development Expenses
- 9.8.5SWOT Analysis
9.9Viatris, Inc.
- 9.9.1Company Overview
- 9.9.2Financial Analysis
- 9.9.3Segmental Analysis
- 9.9.4Research & Development Expense
- 9.9.5SWOT Analysis
9.10.Eli Lilly And Company
- 9.10.1Company Overview
- 9.10.2Financial Analysis
- 9.10.3Regional Analysis
- 9.10.4Research & Development Expenses
- 9.10.5SWOT Analysis

LIST OF TABLES

TABLE 1Europe Androgenetic Alopecia Market, 2019 - 2022, USD Million
TABLE 2Europe Androgenetic Alopecia Market, 2023 - 2030, USD Million
TABLE 3Europe Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
TABLE 4Europe Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
TABLE 5Europe Pharmaceuticals Market, By Country, 2019 - 2022, USD Million
TABLE 6Europe Pharmaceuticals Market, By Country, 2023 - 2030, USD Million
TABLE 7Europe Devices Market, By Country, 2019 - 2022, USD Million
TABLE 8Europe Devices Market, By Country, 2023 - 2030, USD Million
TABLE 9Europe Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
TABLE 10Europe Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
TABLE 11Europe Male Market, By Country, 2019 - 2022, USD Million
TABLE 12Europe Male Market, By Country, 2023 - 2030, USD Million
TABLE 13Europe Female Market, By Country, 2019 - 2022, USD Million
TABLE 14Europe Female Market, By Country, 2023 - 2030, USD Million
TABLE 15Europe Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
TABLE 16Europe Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
TABLE 17Europe Prescriptions Market, By Country, 2019 - 2022, USD Million
TABLE 18Europe Prescriptions Market, By Country, 2023 - 2030, USD Million
TABLE 19Europe OTC Market, By Country, 2019 - 2022, USD Million
TABLE 20Europe OTC Market, By Country, 2023 - 2030, USD Million
TABLE 21Europe Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
TABLE 22Europe Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
TABLE 23Europe Dermatology Clinics Market, By Country, 2019 - 2022, USD Million
TABLE 24Europe Dermatology Clinics Market, By Country, 2023 - 2030, USD Million
TABLE 25Europe Homecare Settings Market, By Country, 2019 - 2022, USD Million
TABLE 26Europe Homecare Settings Market, By Country, 2023 - 2030, USD Million
TABLE 27Europe Androgenetic Alopecia Market, By Country, 2019 - 2022, USD Million
TABLE 28Europe Androgenetic Alopecia Market, By Country, 2023 - 2030, USD Million
TABLE 29Germany Androgenetic Alopecia Market, 2019 - 2022, USD Million
TABLE 30Germany Androgenetic Alopecia Market, 2023 - 2030, USD Million
TABLE 31Germany Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
TABLE 32Germany Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
TABLE 33Germany Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
TABLE 34Germany Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
TABLE 35Germany Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
TABLE 36Germany Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
TABLE 37Germany Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
TABLE 38Germany Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
TABLE 39UK Androgenetic Alopecia Market, 2019 - 2022, USD Million
TABLE 40UK Androgenetic Alopecia Market, 2023 - 2030, USD Million
TABLE 41UK Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
TABLE 42UK Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
TABLE 43UK Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
TABLE 44UK Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
TABLE 45UK Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
TABLE 46UK Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
TABLE 47UK Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
TABLE 48UK Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
TABLE 49France Androgenetic Alopecia Market, 2019 - 2022, USD Million
TABLE 50France Androgenetic Alopecia Market, 2023 - 2030, USD Million
TABLE 51France Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
TABLE 52France Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
TABLE 53France Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
TABLE 54France Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
TABLE 55France Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
TABLE 56France Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
TABLE 57France Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
TABLE 58France Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
TABLE 59Russia Androgenetic Alopecia Market, 2019 - 2022, USD Million
TABLE 60Russia Androgenetic Alopecia Market, 2023 - 2030, USD Million
TABLE 61Russia Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
TABLE 62Russia Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
TABLE 63Russia Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
TABLE 64Russia Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
TABLE 65Russia Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
TABLE 66Russia Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
TABLE 67Russia Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
TABLE 68Russia Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
TABLE 69Spain Androgenetic Alopecia Market, 2019 - 2022, USD Million
TABLE 70Spain Androgenetic Alopecia Market, 2023 - 2030, USD Million
TABLE 71Spain Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
TABLE 72Spain Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
TABLE 73Spain Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
TABLE 74Spain Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
TABLE 75Spain Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
TABLE 76Spain Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
TABLE 77Spain Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
TABLE 78Spain Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
TABLE 79Italy Androgenetic Alopecia Market, 2019 - 2022, USD Million
TABLE 80Italy Androgenetic Alopecia Market, 2023 - 2030, USD Million
TABLE 81Italy Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
TABLE 82Italy Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
TABLE 83Italy Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
TABLE 84Italy Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
TABLE 85Italy Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
TABLE 86Italy Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
TABLE 87Italy Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
TABLE 88Italy Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
TABLE 89Rest of Europe Androgenetic Alopecia Market, 2019 - 2022, USD Million
TABLE 90Rest of Europe Androgenetic Alopecia Market, 2023 - 2030, USD Million
TABLE 91Rest of Europe Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
TABLE 92Rest of Europe Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
TABLE 93Rest of Europe Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
TABLE 94Rest of Europe Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
TABLE 95Rest of Europe Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
TABLE 96Rest of Europe Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
TABLE 97Rest of Europe Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
TABLE 98Rest of Europe Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
TABLE 99Key Information - Cipla Limited
TABLE 100Key Information - Merck & Co., Inc.
TABLE 101Key Information - GlaxoSmithKline PLC
TABLE 102Key Information - Sun Pharmaceuticals Industries Ltd.
TABLE 103Key Information - Dr. Reddy's Laboratories Ltd.
TABLE 104key information - Aurobindo Pharma Limited
TABLE 105Key Information - Pfizer, Inc.
TABLE 106Key Information - lUTRONIC cO., lTD.
TABLE 107key information - Viatris, Inc.
TABLE 108Key Information - Eli Lilly And Company

Europe Androgenetic Alopecia Market Size, Share & Trends Analysis Report By Treatment (Pharmaceuticals, and Devices), By Gender (Male, and Female), By Sales Channel, By Country and Growth Forecast, 2023 - 2030

Description

Table of Contents